TreeWAS – Variant ID: rs17019682

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z85.4 Personal history of malignant neoplasm of genital organs	0.000	0.982	0.018
C77.3 Axillary and upper limb lymph nodes	0.007	0.993	0.000
N92.6 Irregular menstruation, unspecified	0.000	0.994	0.006
N92.1 Excessive and frequent menstruation with irregular cycle	0.000	0.994	0.006
K29.1 Other acute gastritis	0.006	0.994	0.000
N92 Excessive, frequent and irregular menstruation	0.000	0.995	0.005
M25.77 Osteophyte (Ankle and foot)	0.000	0.995	0.005
I20.0 Unstable angina	0.005	0.995	0.000
J30.1 Allergic rhinitis due to pollen	0.000	0.995	0.005
D23.6 Skin of upper limb, including shoulder	0.000	0.996	0.004
M25.75 Osteophyte (Pelvic region and thigh)	0.000	0.996	0.004
N92.3 Ovulation bleeding	0.000	0.996	0.004
Z02.8 Other examinations for administrative purposes	0.004	0.996	0.000
M25.7 Osteophyte	0.000	0.996	0.004
N92.2 Excessive menstruation at puberty	0.000	0.996	0.004
N92.4 Excessive bleeding in the premenopausal period	0.000	0.996	0.004
M54.22 Cervicalgia (Cervical region)	0.004	0.996	0.000
M25.74 Osteophyte (Hand)	0.000	0.996	0.004
N80.1 Endometriosis of ovary	0.000	0.996	0.004
Z00.0 General medical examination	0.004	0.996	0.000
N70.1 Chronic salpingitis and oophoritis	0.000	0.996	0.003
N92.0 Excessive and frequent menstruation with regular cycle	0.000	0.997	0.003
M25.72 Osteophyte (Upper arm)	0.000	0.997	0.003
M25.71 Osteophyte (Shoulder region)	0.000	0.997	0.003
M25.79 Osteophyte (Site unspecified)	0.000	0.997	0.003
M25.73 Osteophyte (Forearm)	0.000	0.997	0.003
M25.70 Osteophyte (Multiple sites)	0.000	0.997	0.003
N92.5 Other specified irregular menstruation	0.000	0.997	0.003
N80 Endometriosis	0.000	0.997	0.003
M25.78 Osteophyte (Other)	0.000	0.997	0.003
N80.8 Other endometriosis	0.000	0.997	0.003
I47.1 Supraventricular tachycardia	0.003	0.997	0.000
N80.0 Endometriosis of uterus	0.000	0.997	0.003
M25.76 Osteophyte (Lower leg)	0.000	0.997	0.003
N88.8 Other specified noninflammatory disorders of cervix uteri	0.003	0.997	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.003	0.997	0.000
Y45.0 Opioids and related analgesics	0.003	0.997	0.000
N80.9 Endometriosis, unspecified	0.000	0.997	0.003
N80.2 Endometriosis of Fallopian tube	0.000	0.997	0.003
Y44.2 Anticoagulants	0.003	0.997	0.000
K51.8 Other ulcerative colitis	0.000	0.997	0.003
C49 Malignant neoplasm of other connective and soft tissue	0.003	0.997	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.997	0.003
C49.0 Connective and soft tissue of head, face and neck	0.003	0.997	0.000
K51 Ulcerative colitis	0.000	0.997	0.003
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
N70 Salpingitis and oophoritis	0.000	0.997	0.003
C49.2 Connective and soft tissue of lower limb, including hip	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
N80.6 Endometriosis in cutaneous scar	0.000	0.997	0.002
N80.4 Endometriosis of rectovaginal septum and vagina	0.000	0.997	0.002
C49.1 Connective and soft tissue of upper limb, including shoulder	0.002	0.997	0.000
K51.4 Pseudopolyposis of colon	0.000	0.997	0.003
J84.1 Other interstitial pulmonary diseases with fibrosis	0.000	0.997	0.003
Y40 Systemic antibiotics	0.002	0.997	0.000
K51.2 Ulcerative (chronic) proctitis	0.000	0.998	0.002
O70.0 First degree perineal laceration during delivery	0.000	0.998	0.002
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
M54.2 Cervicalgia	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
I35.0 Aortic (valve) stenosis	0.002	0.998	0.000
Y40.0 Penicillins	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
N80.5 Endometriosis of intestine	0.000	0.998	0.002
G30.9 Alzheimer's disease, unspecified	0.002	0.998	0.000
K51.9 Ulcerative colitis, unspecified	0.000	0.998	0.002
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
C45.0 Mesothelioma of pleura	0.002	0.998	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.000	0.998	0.002
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
M54.29 Cervicalgia-Site unspe	0.002	0.998	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.002	0.998	0.000
C49.9 Connective and soft tissue, unspecified	0.002	0.998	0.000
C49.8 Overlapping lesion of connective and soft tissue	0.002	0.998	0.000
C49.6 Connective and soft tissue of trunk, unspecified	0.002	0.998	0.000
C49.5 Connective and soft tissue of pelvis	0.002	0.998	0.000
C49.4 Connective and soft tissue of abdomen	0.002	0.998	0.000
C49.3 Connective and soft tissue of thorax	0.002	0.998	0.000
C45 Mesothelioma	0.002	0.998	0.000
C48.2 Peritoneum, unspecified	0.002	0.998	0.000
K51.5 Mucosal proctocolitis	0.000	0.998	0.002
K51.1 Ulcerative (chronic) ileocolitis	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.002	0.998	0.000
N70.0 Acute salpingitis and oophoritis	0.000	0.998	0.002
T40.2 Other opioids	0.000	0.998	0.002
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
H66.3 Other chronic suppurative otitis media	0.002	0.998	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.998	0.002
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.002	0.998	0.000
K14.8 Other diseases of tongue	0.002	0.998	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.000	0.998	0.002
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
Y40.6 Rifamycins	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
C45.7 Mesothelioma of other sites	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
Y45.4 Antirheumatics	0.002	0.998	0.000
M54.28 Cervicalgia-Sacral/sacrococ	0.002	0.998	0.000
M54.27 Cervicalgia-Lumbosacral	0.002	0.998	0.000
M54.26 Cervicalgia-Lumbar	0.002	0.998	0.000
M54.25 Cervicalgia-Thoracolumbar	0.002	0.998	0.000
M54.24 Cervicalgia-Thoracic	0.002	0.998	0.000
M54.23 Cervicalgia (Cervicothoracic region)	0.002	0.998	0.000
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.002	0.998	0.000
M54.20 Cervicalgia-Mult site	0.002	0.998	0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.000	0.998	0.002
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
G30 Alzheimer's disease	0.002	0.998	0.000
J30 Vasomotor and allergic rhinitis	0.000	0.998	0.002
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
F03 Unspecified dementia	0.002	0.998	0.000
C48.1 Specified parts of peritoneum	0.002	0.998	0.000
N73.6 Female pelvic peritoneal adhesions	0.000	0.998	0.002
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
G31.1 Senile degeneration of brain, not elsewhere classified	0.002	0.998	0.000
G31.0 Circumscribed brain atrophy	0.002	0.998	0.000
Z02 Examination and encounter for administrative purposes	0.002	0.998	0.000
C45.2 Mesothelioma of pericardium	0.002	0.998	0.000
C45.1 Mesothelioma of peritoneum	0.002	0.998	0.000
G31.8 Other specified degenerative diseases of nervous system	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
G31.2 Degeneration of nervous system due to alcohol	0.002	0.998	0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.002	0.998	0.000
C48.0 Retroperitoneum	0.002	0.998	0.000
Y43 Primarily systemic agents	0.002	0.998	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.000	0.998	0.002
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
C45.9 Mesothelioma, unspecified	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.002	0.998	0.000
C46 Kaposi's sarcoma	0.002	0.998	0.000
N81.5 Vaginal enterocele	0.000	0.998	0.002
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
Y43.4 Immunosuppressive agents	0.002	0.998	0.000
G12.2 Motor neuron disease	0.000	0.998	0.002
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
N73 Other female pelvic inflammatory diseases	0.000	0.998	0.002
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.000	0.998	0.002
N70-N77 Inflammatory diseases of female pelvic organs	0.000	0.998	0.002
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
G30.8 Other Alzheimer's disease	0.002	0.998	0.000
G30.1 Alzheimer's disease with late onset	0.002	0.998	0.000
G30.0 Alzheimer's disease with early onset	0.002	0.998	0.000
J30.3 Other allergic rhinitis	0.000	0.998	0.002
J30.2 Other seasonal allergic rhinitis	0.000	0.998	0.002
J30.0 Vasomotor rhinitis	0.000	0.998	0.002
Y54.3 Benzothiadiazine derivatives	0.001	0.998	0.000
E55.9 Vitamin D deficiency, unspecified	0.002	0.998	0.000
N32.9 Bladder disorder, unspecified	0.002	0.998	0.000
N81.2 Incomplete uterovaginal prolapse	0.000	0.998	0.002
J44 Other chronic obstructive pulmonary disease	0.000	0.998	0.002
J84 Other interstitial pulmonary diseases	0.000	0.998	0.002
G30-G32 Other degenerative diseases of the nervous system	0.002	0.998	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.002	0.998	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.000	0.998	0.002
Y45.1 Salicylates	0.001	0.998	0.000
N71 Inflammatory disease of uterus, except cervix	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
M13.90 Arthritis, unspecified (Multiple sites)	0.000	0.998	0.002
N71.9 Inflammatory disease of uterus, unspecified	0.000	0.998	0.002
N80.3 Endometriosis of pelvic peritoneum	0.000	0.998	0.002
Z02.9 Examination for administrative purposes, unspecified	0.001	0.998	0.000
Z02.7 Issue of medical certificate	0.001	0.998	0.000
Z02.6 Examination for insurance purposes	0.001	0.998	0.000
Z02.5 Examination for participation in sport	0.001	0.998	0.000
Z02.4 Examination for driving licence	0.001	0.998	0.000
Z02.3 Examination for recruitment to armed forces	0.001	0.998	0.000
Z02.2 Examination for admission to residential institution	0.001	0.998	0.000
Z02.1 Pre-employment examination	0.001	0.998	0.000
Z02.0 Examination for admission to educational institution	0.001	0.998	0.000
J30.4 Allergic rhinitis, unspecified	0.000	0.998	0.001
H91.9 Hearing loss, unspecified	0.000	0.998	0.002
F31.7 Bipolar affective disorder, currently in remission	0.002	0.998	0.000
S01.9 Open wound of head, part unspecified	0.000	0.998	0.002
Y43.9 Primarily systemic agent, unspecified	0.001	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.001	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.001	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.001	0.998	0.000
Y43.2 Antineoplastic natural products	0.001	0.998	0.000
Y43.1 Antineoplastic antimetabolites	0.001	0.998	0.000
C46.9 Kaposi's sarcoma, unspecified	0.001	0.998	0.000
C46.8 Kaposi's sarcoma of multiple organs	0.001	0.998	0.000
C46.7 Kaposi's sarcoma of other sites	0.001	0.998	0.000
C46.3 Kaposi's sarcoma of lymph nodes	0.001	0.998	0.000
C46.2 Kaposi's sarcoma of palate	0.001	0.998	0.000
C46.1 Kaposi's sarcoma of soft tissue	0.001	0.998	0.000
C46.0 Kaposi's sarcoma of skin	0.001	0.998	0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.001	0.998	0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.001	0.998	0.000
C47.6 Peripheral nerves of trunk, unspecified	0.001	0.998	0.000
C47.5 Peripheral nerves of pelvis	0.001	0.998	0.000
C47.4 Peripheral nerves of abdomen	0.001	0.998	0.000
C47.3 Peripheral nerves of thorax	0.001	0.998	0.000
C47.2 Peripheral nerves of lower limb, including hip	0.001	0.998	0.000
C47.1 Peripheral nerves of upper limb, including shoulder	0.001	0.998	0.000
C47.0 Peripheral nerves of head, face and neck	0.001	0.998	0.000
J44.9 Chronic obstructive pulmonary disease, unspecified	0.000	0.998	0.002
N73.8 Other specified female pelvic inflammatory diseases	0.000	0.998	0.001
N73.5 Female pelvic peritonitis, unspecified	0.000	0.998	0.001
N73.4 Female chronic pelvic peritonitis	0.000	0.998	0.001
N73.3 Female acute pelvic peritonitis	0.000	0.998	0.001
N73.2 Unspecified parametritis and pelvic cellulitis	0.000	0.998	0.001
N73.1 Chronic parametritis and pelvic cellulitis	0.000	0.998	0.001
N73.0 Acute parametritis and pelvic cellulitis	0.000	0.998	0.001
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.001	0.998	0.000
Z13.6 Special screening examination for cardiovascular disorders	0.000	0.998	0.002
N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere	0.000	0.998	0.001
N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.001
T40.4 Other synthetic narcotics	0.000	0.998	0.001
N74 Female pelvic inflammatory disorders in diseases classified elsewhere	0.000	0.998	0.001
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.001
J84.8 Other specified interstitial pulmonary diseases	0.000	0.999	0.001
J84.0 Alveolar and parietoalveolar conditions	0.000	0.999	0.001
N87.1 Moderate cervical dysplasia	0.000	0.999	0.001
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.001	0.999	0.000
N88 Other noninflammatory disorders of cervix uteri	0.001	0.999	0.001
Q15.0 Congenital glaucoma	0.001	0.999	0.000
Q85.8 Other phakomatoses, not elsewhere classified	0.001	0.999	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.999	0.001
T40.8 Lysergide [LSD]	0.000	0.999	0.001
T40.7 Cannabis (derivatives)	0.000	0.999	0.001
T40.6 Other and unspecified narcotics	0.000	0.999	0.001
T40.5 Cocaine	0.000	0.999	0.001
T40.3 Methadone	0.000	0.999	0.001
T40.1 Heroin	0.000	0.999	0.001
T40.0 Opium	0.000	0.999	0.001
N71.0 Acute inflammatory disease of uterus	0.000	0.999	0.001
N73.9 Female pelvic inflammatory disease, unspecified	0.000	0.999	0.001
Q21.0 Ventricular septal defect	0.001	0.999	0.000
N75 Diseases of Bartholin's gland	0.000	0.999	0.001
Z00 General examination and investigation of persons without complaint or reported diagnosis	0.001	0.999	0.000
M48.09 Spinal stenosis (Site unspecified)	0.000	0.999	0.001
T78.4 Allergy, unspecified	0.001	0.999	0.000
K55.2 Angiodysplasia of colon	0.001	0.999	0.000
I07.1 Tricuspid insufficiency	0.001	0.999	0.000
N71.1 Chronic inflammatory disease of uterus	0.000	0.999	0.001
Q85 Phakomatoses, not elsewhere classified	0.001	0.999	0.000
N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere	0.000	0.999	0.001
N74.4 Female chlamydial pelvic inflammatory disease	0.000	0.999	0.001
N74.3 Female gonococcal pelvic inflammatory disease	0.000	0.999	0.001
N74.2 Female syphilitic pelvic inflammatory disease	0.000	0.999	0.001
N74.1 Female tuberculous pelvic inflammatory disease	0.000	0.999	0.001
N74.0 Tuberculous infection of cervix uteri	0.000	0.999	0.001
Q79.6 Ehlers-Danlos syndrome	0.001	0.999	0.000
Z00.4 General psychiatric examination, not elsewhere classified	0.001	0.999	0.000
Q15 Other congenital malformations of eye	0.001	0.999	0.000
N94.6 Dysmenorrhoea, unspecified	0.000	0.999	0.001
Q23.1 Congenital insufficiency of aortic valve	0.001	0.999	0.000
Z49.1 Extracorporeal dialysis	0.001	0.999	0.000
Q24 Other congenital malformations of heart	0.001	0.999	0.000
G32.8 Other specified degenerative disorders of nervous system in diseases classified elsewhere	0.001	0.999	0.000
G32.0 Subacute combined degeneration of spinal cord in diseases classified elsewhere	0.001	0.999	0.000
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.001	0.999	0.001
N88.4 Hypertrophic elongation of cervix uteri	0.001	0.999	0.001
N88.3 Incompetence of cervix uteri	0.001	0.999	0.001
N88.1 Old laceration of cervix uteri	0.001	0.999	0.001
N88.0 Leukoplakia of cervix uteri	0.001	0.999	0.001
Q24.9 Congenital malformation of the heart, unspecified	0.001	0.999	0.000
Q82.5 Congenital nonneoplastic naevus	0.001	0.999	0.000
F31 Bipolar affective disorder	0.001	0.999	0.000
Q23 Congenital malformations of aortic and mitral valves	0.001	0.999	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.999	0.001
Y42.5 Other oestrogens and progestogens	0.001	0.999	0.000
Z49.0 Preparatory care for dialysis	0.001	0.999	0.000
Q82 Other congenital malformations of skin	0.001	0.999	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.001	0.999	0.000
N75.0 Cyst of Bartholin's gland	0.000	0.999	0.001
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.999	0.001
T78.3 Angioneurotic oedema	0.001	0.999	0.000
Y84.0 Cardiac catheterisation	0.001	0.999	0.000
Z00.8 Other general examinations	0.001	0.999	0.000
Z00.5 Examination of potential donor of organ and tissue	0.001	0.999	0.000
Z00.3 Examination for adolescent development state	0.001	0.999	0.000
Z00.2 Examination for period of rapid growth in childhood	0.001	0.999	0.000
Z00.1 Routine child health examination	0.001	0.999	0.000
Q79 Congenital malformations of musculoskeletal system, not elsewhere classified	0.001	0.999	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.999	0.001
Q80-Q89 Other congenital malformations	0.001	0.999	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.001	0.999	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.001	0.999	0.000
H72.2 Other marginal perforations of tympanic membrane	0.001	0.999	0.000
N75.9 Disease of Bartholin's gland, unspecified	0.000	0.999	0.001
N75.8 Other diseases of Bartholin's gland	0.000	0.999	0.001
N81.6 Rectocele	0.000	0.999	0.001
H66 Suppurative and unspecified otitis media	0.001	0.999	0.000
N76 Other inflammation of vagina and vulva	0.000	0.999	0.001
N72 Inflammatory disease of cervix uteri	0.000	0.999	0.001
Q21 Congenital malformations of cardiac septa	0.001	0.999	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.001	0.999	0.000
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)	0.001	0.999	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.001	0.999	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.000	0.999	0.001
Q24.8 Other specified congenital malformations of heart	0.001	0.999	0.000
Q66.8 Other congenital deformities of feet	0.001	0.999	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.999	0.001
Z86.1 Personal history of infectious and parasitic diseases	0.001	0.999	0.000
Q66 Congenital deformities of feet	0.001	0.999	0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.001	0.999	0.000
F30.2 Mania with psychotic symptoms	0.001	0.999	0.000
H72.0 Central perforation of tympanic membrane	0.001	0.999	0.000
N94.9 Unspecified condition associated with female genital organs and menstrual cycle	0.000	0.999	0.001
Q15.9 Congenital malformation of eye, unspecified	0.001	0.999	0.000
Q15.8 Other specified congenital malformations of eye	0.001	0.999	0.000
Q85.9 Phakomatosis, unspecified	0.001	0.999	0.000
Q85.1 Tuberous sclerosis	0.001	0.999	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.001	0.999	0.000
F00 Dementia in Alzheimer's disease	0.001	0.999	0.000
N94 Pain and other conditions associated with female genital organs and menstrual cycle	0.000	0.999	0.001
N94.8 Other specified conditions associated with female genital organs and menstrual cycle	0.000	0.999	0.001
Q07.0 Arnold-Chiari syndrome	0.001	0.999	0.000
Q24.6 Congenital heart block	0.001	0.999	0.000
Q24.5 Malformation of coronary vessels	0.001	0.999	0.000
Q24.4 Congenital subaortic stenosis	0.001	0.999	0.000
Q24.3 Pulmonary infundibular stenosis	0.001	0.999	0.000
Q24.2 Cor triatriatum	0.001	0.999	0.000
Q24.1 Levocardia	0.001	0.999	0.000
Q24.0 Dextrocardia	0.001	0.999	0.000
Q54.9 Hypospadias, unspecified	0.001	0.999	0.000
Y87.1 Sequelae of assault	0.001	0.999	0.000
Q18 Other congenital malformations of face and neck	0.001	0.999	0.000
F05.8 Other delirium	0.001	0.999	0.000
F31.8 Other bipolar affective disorders	0.001	0.999	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.001	0.999	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.001	0.999	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.001	0.999	0.000
K72.9 Hepatic failure, unspecified	0.000	0.999	0.001
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.001	0.999	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.001	0.999	0.000
Q23.4 Hypoplastic left heart syndrome	0.001	0.999	0.000
Q23.3 Congenital mitral insufficiency	0.001	0.999	0.000
Q23.2 Congenital mitral stenosis	0.001	0.999	0.000
Q23.0 Congenital stenosis of aortic valve	0.001	0.999	0.000
W49.0 Home	0.001	0.999	0.000
Z71.8 Other specified counselling	0.001	0.999	0.000
F05 Delirium, not induced by alcohol and other psychoactive substances	0.001	0.999	0.000
H72 Perforation of tympanic membrane	0.001	0.999	0.000
Q12 Congenital lens malformations	0.001	0.999	0.000
Q27 Other congenital malformations of peripheral vascular system	0.001	0.999	0.000
Q26 Congenital malformations of great veins	0.001	0.999	0.000
Q25 Congenital malformations of great arteries	0.001	0.999	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.001	0.999	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations